Introduction
Operations on the biliary tract carry a definite incidence of postoperative infection which falls into two groups-wound infection and infections involving the biliary tract and the associated area of peritoneum. In the latter group severe complications occasionally ensue, such as subphrenic abscess and even septicaemia (Maingot, 1963) . Contamination during operation may lead to wound infection with Gram-negative bacilli or Streptococcus faecalis from the infected bile, perhaps aided by the spreading quality of bile resulting from its low surface tension. A further predisposing factor to wound infection is increased obesity of the abdominal wall, also making chest infection more likely. Infections of the biliary tract can progress to cholangiohepatitis, pancreatitis, or local peritonitis, especially in the presence of stones or stricture formation in the common bile duct, with or without obstruction.
The antibiotics most commonly used to treat acute cholecystitis and to "cover" operations on the infected gall bladder are tetracycline and ampicillin, as these reach high concentrations in the bile (Ayliffe and Davies, 1965) .
The rifamycin group of antibiotics are derived from Streptomyces mediterranei, and one of the group, rifamycin B, is the parent substance of two compounds recently introduced into England by Lepitit Laboratories. The antibacterial spectrum of the two compounds is similar and includes activity against mycobacteria. Rifampicin is being used to treat tuberculosis. Rifamide (Rifocin) is mainly excreted in unchanged form in the bile, and bile levels after a 100-mg dose intramuscularly can reach more than 1,000 tLg/ml (Furesz et al., 1965; Stratford and Dixson, 1966) . These levels exceed the minimum inhibitory concentrations of most Gram-negative bacilli likely to be found in bile-Escherichia coli, Klebsiella, Salmonella, and Proteus spp., and Str. faecalis (Furesz et al., 1965) . These levels are higher than those of antibiotics commonly used for biliary infections, including tetracycline, ampicillin, novobiocin, and erythromycin. The levels in the wall of the gall bladder are also high.
We 285 one mucocele was found at operation. Apart from these findings the groups showed similar features. Table II shows the incidence of clinical infection at several sites in the two groups and the results of bacteriological examination. A similar percentage of chest infections occurred in the two groups. In the control group one patient developed ascending cholangitis and five patients developed wound infections, the organisms isolated from these wounds being of faecal origin, but two wounds acquiring a staphylococcus in addition. Only one patient in the rifamide group developed clinical wound infection. Cultures of bile from the rifamide group yielded five organisms from three patients, and in the control group 13 organisms from eight patients (t 2-1, P <0 05). Organisms were isolated from sputum with equal frequency in both groups. Antibiotics were given significantly more often in the control group, where 63% of the patients needed antibiotic therapy, compared with 33% in the rifamide group (t 2-38, P <0.05). In the rifamide group antibiotics were given predominantly for chest infections (Table III) . The average length of stay in hospital postoperatively did not differ appreciably, but all the rifamide-treated patients were discharged on or before the eighteenth postoperative day, whereas five of the control group remained for 20 or more days.
The effect of the presence of acute cholecystitis on the outcome of operation is shown in Table IV . Of the seven patients with evidence of acute inflammation at the time of operation who received antibiotics other than rifamide (and were therefore in the control group), three had infected bile and the same three subsequently developed wound infections. These seven patients stayed in hospital an average of 20-7 days postoperatively (10, 13, 16, 20, 21, 24 , and 43 days), significantly longer than the 12-7 days of 11 patients with acute cholecystitis receiving rifamide (10, 10, 10, 10, 12, 13, 13, 14, 14, 15 , and 17 days). When there was evidence of past acute infection but no present acute episode, the differences between the two groups of patients was less pronounced (Table IV) .
The sensitivity of the organisms isolated from the biliary tract of the patients in the two groups is shown in Table V. In the rifamide group one organism, an E. coli, was found to be resistant to more than 500 t±g of rifamide per ml., and this was in the only patient in the group to develop a wound infection, the same strain of E. coli being isolated. All the organisms isolated from the control group were inhibited by 500 j±g/ml and all but two by 100 Lg/ml.
Acute cholecystitis
In this series 18 patients were admitted with acute cholecystitis (Table IV) ; 11 of these were in the rifamide group and eight were clinically mild, while six of the seven in the control group were mild. Clinically, there was no marked difference in the response to preoperative treatment of the mild cases in the two groups. However, the three severe cases showed a pronounced response to rifamide, with improvement in the general condition, resolution of pyrexia, and localization with lessening of the abdominal signs; an operation of election was possible in all three cases. The severe case in the control group, treated with tetracycline, showed no such response to treatment and needed an emergency operation 48 hours after admission. (1958) found that biliary operations formed the second commonest group, involving 6°' of cases. Payne (1969) found an incidence of 5%043 wound infections in 924 biliary operations.
These were both retrospective surveys, and the real incidence is probably higher. Robson et al. (1970) found an incidence of 15%, similar to the incidence in our series of control patients, where 5 out of 27 patients (18%) had a wound infection (Table  II) . The organisms present in the gall bladder at operation bear a direct relationship to the resulting wound infection when this occurs. In all cases with wound infection the same organism was invariably found also in the gall bladder. The presence of an organism in the gall bladder did not necessarily lead to a wound infection, but no cases of wound infection occurred in patients in whom the bile was sterile at operation. It therefore seems important to try to sterilize the bile before operation is undertaken. The high prevalence of infected bile is shown by the fact that 8 of the 27 control cases had infected bile at operation, despite previous antibiotic therapy in several cases. The use of rifamide before operation substantially reduced the number of patients with infected bile.
Before the introduction of rifamide the two antibiotics mainly used in biliary infections were tetracycline and ampicillin, because these antibiotics are the only two which are concentrated in bile and which have, in addition, a therapeutically acceptable activity against the likely pathogens. The levels of rifamide attainable in the biliary tract also exceed the minimum inhibitory concentration of practically all strains. The only rifamycin-resistant strain isolated was from a patient who had been receiving rifamycin before operation. This strain was not isolated from the bile at operation but was grown from a T-tube two days subsequently.
The objective in giving rifamide to patients undergoing biliary surgery is to sterilize the bile, and therefore the high levels obtainable have some significance. In treating acute cholecystitis and cholangitis, however, the level in the bile might not be so important as the level of the antibiotic which is attainable in the liver tissue. The rapid response of acute cholecystitis to rifamide suggests that the levels in the liver substance may be quite high, because the minimum inhibitory concentration of rifamycin for Gram-negative bacilli is commonly in the neighbourhood of 20-50 ,ug/ml-that is, higher than the blood level ofthe antibiotic.
Prophylactic antibiotic therapy is often used in surgery, but because many of the uses appear to be empirical this type of therapy is usually frowned on. The reasons for considering such therapy in biliary surgery are that the gall bladder is often infected and wound infections are common after cholecystectomy. The organisms found in the gall bladder are usually derived from the bowel, and at the levels attained by rifamide in the bile most infecting organisms are sensitive.
Residual infection in the bile after cholecystectomy can lead to recurrent stone formation in the common bile duct. A further justification for prophylaxis is to establish sterility of the bile from the time the gall bladder is removed. In order to reach an effective concentration in the bile the rifamide was given for 24 hours beforehand.
Another bacteriological characteristic of rifamide thought to be of possible value was its high activity against the respiratory pathogens Str. pneunomae and H. influenzae. However, the incidence of chest infection was the same in both groups of patients. This is probably related to the poor penetration of rifamycin into the bronchial secretion (Citron and May, 1969 We wish to thank Miss Linda Glaze for technical help and Miss Vivian Barlow for secretarial services. Dr. C. D. Granger, of Lepetit Pharmaceuticals, kindly arranged a generous supply of rifamide (Rifocin-M).
Introduction
There are several possible approaches to the symptomatic relief of severe pain-namely, interruption of afferent nerve pathways, either chemically or surgically; "dissociation" of the patient from his pain, which may be achieved by such psychological devices as suggestion or hypnosis, or pharmacologically by agents such as chlorpromazine; and use of centrally acting analgesics, which may also produce mild sedation and dissociate patients from their pain. Only the latter, which involves the systemic use of drugs with opiate-like actions, offers ease of administration compatible with everyday clinical practice. It is therefore of importance that the relative merits of the numerous available drugs of this class should be established. Though the literature relating to these substances is abundant reports have usually encompassed only a few agents, and lack of standardized methodology makes the compiling of an overall assessment difficult.
The study reported here, which occupied four years, was undertaken to answer this need. 
Method and Material
The method has been previously described and presented with a critical assessment of its sensitivity and validity (Loan et al., 1968) . Patients who had undergone upper or lower abdominal surgery were admitted to the trial when the nursing staff considered that they required their first postoperative analgesic. Pain severity was assessed before and after treatment on four criteria-namely, patient's and observer's subjective estimates on a five-point scale and, with upper abdominal wounds, measurements of vital capacity and peak expiratory flow rate. Pain relief was inferred from changes in these criteria and also estimated by the patient's direct retrospective comparison with his pretreatment state. Treatment in any individual patient was classified as a success only when all these criteria showed improvement, and this "overall" assessment was used in the final comparison of drugs.
The study was carried out in the same environment by two observers who were successive full-time research workers. Drugs were administered and assessments made under doubleblind conditions.
The preparations, doses, and numbers of patients given each drug are listed in Table I , and mean ages and weights of patients are shown in Table II . Ideally, each drug should be included at several dose levels so that the basis of comparison would be dose/response curves, thus eliminating differences due solely to dosage. In practice such an approach would have required a vastly greater number of subjects and would have extended the time far beyond the four years taken to complete this study, which was mainly concerned with com- 
